Further, ZAP-70 expression can enhance BCR signaling after anti-IgM treatment, independent of its kinase activity[44], and CLL cells that expressed ZAP-70 had significantly higher levels of phosphorylated CD79b compared to CLL lacking ZAP-70. This evidence concerns the gene ZAP70 and B-cell chronic lymphocytic leukemia.